ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Quinapril/Hydrochlorothiazide Tablet shortage

Current  6 presentations · 2 manufacturers · first FDA posting 2023-01-19 · last update 2026-10-02

Manufacturers: Aurobindo Pharma USA, Chartwell Molecular Holdings LLC

Stated reasons (per FDA): Discontinuation of the manufacture of the drug

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90)Aurobindo Pharma USACurrent
Unavailable
 Discontinuation of the manufacture of the drugDiscontinuation of the manufacture of the drugPosted 01/19/2023
Updated 10/02/2026
Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90)Aurobindo Pharma USACurrent
Unavailable
 Discontinuation of the manufacture of the drugDiscontinuation of the manufacture of the drugPosted 01/19/2023
Updated 10/02/2026
Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90)Aurobindo Pharma USACurrent
Unavailable
 Discontinuation of the manufacture of the drugDiscontinuation of the manufacture of the drugPosted 01/19/2023
Updated 10/02/2026
Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90)Chartwell Molecular Holdings LLCCurrent
Available
 —Posted 01/19/2023
Updated 10/02/2026
Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90)Chartwell Molecular Holdings LLCCurrent
Available
 —Posted 01/19/2023
Updated 10/02/2026
Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90)Chartwell Molecular Holdings LLCCurrent
Available
 —Posted 01/19/2023
Updated 10/02/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)